获取演示
Now livetag icon
The official Gen AI Landscape report for 2026 is here. Don’t miss out!Get your copybanner icon
Organovo Holdings, Inc.

七月 2026

  • Home
  • Organovo Holdings, Inc.

七月 2026的Organovo Holdings, Inc.市场份额分析

Conventional two dimensional (2D) cell culture models do not reflect the complexity of biological phenomena that occur in the liver microenvironment, resulting in discrepancies between in vitro predictions and in vivo realities. One of the major reasons for these differences is that primary hepatocytes, when isolated and cultured in a 2D monolayer, rapidly lose key […]
成立年份2007
员工51 - 200
年营收$2M - $5M
organovo.com
Organovo Holdings, Inc.
Organovo Holdings, Inc.(包含公司地区分支机构)
  • organovo.com
    organovo.com
查看更多网站流量和参与度信息

Organovo Holdings, Inc.收入截至 七月 2026为 2M - 5M

Organovo Holdings, Inc.主要域名产生的收入

3 年中Organovo Holdings, Inc.主要域名的收入

Organovo Holdings, Inc.主要域名的收入


Organovo Holdings, Inc.热门域名的总访问量

了解Organovo Holdings, Inc.市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细

Organovo Holdings, Inc.热门域名的平均访问时长

分析Organovo Holdings, Inc.参与度指标。

过去 3 个月的平均访问时长

子公司明细

Organovo Holdings, Inc.热门域名的平均页面浏览量

了解Organovo Holdings, Inc.如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细

想要获取更深入的流量洞见?

过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。



Organovo Holdings, Inc. 采用的主要技术

这些是排名前 Organovo Holdings, Inc. 的顶级域名所使用的网站技术(按行业分列)

小部件 (4)

付费广告 (2)

Google Adsense

Google Adsense

视听媒体 (2)

内容管理系统 (2)

WordPress

WordPress

更多技术

11

查看全部

准备好发现优质潜在客户了吗?

借助 Similarweb 销售情报解决方案,确定任意网站使用了哪些技术来设计完美的销售宣传,并缩短销售周期。


Organovo Holdings, Inc. 的新闻与信号

借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。

新闻L’Oréal Group partnered with Organovo Inc. on Jan 1st '15.In 2015, L'Oreal partnered with 3D-bioprinting firm Organovo to figure out a way to 3D print skin tissue.
新闻Organovo Holdings, Inc. attends event Annual Meeting.In a recent Annual Meeting, Organovo expanded its equity incentive plan by 1,775,000 shares, following stockholder approval.
新闻Organovo Holdings, Inc. is developing novel treatment approaches in inflammatory bowel disease.SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) - Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today announced that it had appointed Norman Staskey as Chief Financial Officer.

查看 Organovo Holdings, Inc. 的所有信号

让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。